I am pleased to announce that effective immediately Joel Neal, MD has been named the new Medical Director for the Cancer Clinical Trials Office of the Stanford Cancer Institute (SCI). This leadership role provides critical oversight for day-to-day operations of the cancer clinical research enterprise, including ensuring the SCI’s clinical research infrastructure is aligned to support clinical research strategic goals and ensuring that CCTO meets the NCI requirements of the Clinical Protocol and Data Management (CPDM) functions for the NCI Cancer Center Support Grant (CCSG). I am grateful to Joel for his willingness to take on this new leadership responsibility. I would also like to thank Heather Wakelee, MD who has served in this position since 2013 and has been elevated to become the new Deputy Director of the SCI. Please join me in congratulating both Joel and Heather.